BIIB - Biogen Idec Inc., is involved in the development, manufacturing and commercialization of therapies in the areas of oncology, neurology and immunology. The Company has five products: AVONEX (interferon beta-1a), RITUXAN (rituximab), TYSABRI (natalizumab), ZEVALIN (ibritumomab tiuxetan) and FUMADERM (dimethylfumarate and monoethylfumarate salts). News .. Financial Highlights .. Analyst Estimates .. Option Chain .. IV ..Candlestick Analysis..Short Interest.
Market Data 
Markets 
AI
